To continue reading this article, you must log in with your personal, organization, or group practice subscription.
For more information or to purchase a personal subscription, click below to see pricing.
The quality of evidence is downgraded by study limitations (high attrition rates) and publication bias (all studies funded by GlaxoSmithKline, the producer of bupropion XL).
A Cochrane review ...
To continue reading this article, you must log in with your personal, organization, or group practice subscription.
For more information or to purchase a personal subscription, click below to see pricing.
|
|